More tools:Markets·Screener·Research·Chat

Alkermes Inc. plc (ALKS) Financial Statements

Alkermes Inc. plc
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S6RXM7
XNAS · usd
45.49▼ 0.61 (-1.32%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close46.10
Day's Range44.63 – 46.53
52-Week Range25.17 – 55.67
Volume1.4M
Avg Volume1.5M
Share Statistics
Shares Outstanding
Employees2,050
ExchangeXNAS
Listed1991-07-16
Share count as of July 23, 2026
Loading Income Statement…
Key questions about Alkermes Inc. plc (ALKS)
What is Alkermes Inc. plc's Market Cap?
Alkermes Inc. plc's Market Cap is $7.6B, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Enterprise Value?
Alkermes Inc. plc's Enterprise Value is $8.6B, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Trailing P/E?
Alkermes Inc. plc's Trailing P/E is 115.4×, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Price / Sales?
Alkermes Inc. plc's Price / Sales is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's EV / Revenue?
Alkermes Inc. plc's EV / Revenue is 5.2×, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's EV / EBITDA?
Alkermes Inc. plc's EV / EBITDA is 48.2×, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Revenue (TTM)?
Alkermes Inc. plc's Revenue (TTM) is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Net Income (TTM)?
Alkermes Inc. plc's Net Income (TTM) is $66.1M, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's EBITDA?
Alkermes Inc. plc's EBITDA is $178.9M, based on as-reported figures from SEC (XBRL) filings.
What is Alkermes Inc. plc's Diluted EPS (TTM)?
Alkermes Inc. plc's Diluted EPS (TTM) is 0.39, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUES:
Total revenues
YoY growth+27.0%+28.2%-10.6%+4.2%
EXPENSES:
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)
Research and development
Selling, general and administrative
Change in fair value of contingent consideration———
Amortization of acquired intangible assets
Total expenses
% of revenue96.3%112.3%84.9%77.4%
OPERATING (LOSS) INCOME
% of revenue3.7%-12.3%15.1%22.6%
OTHER (EXPENSE) INCOME, NET:
Interest income
Interest expense
Other (expense) income, net
Total other (expense) income, net
(LOSS) INCOME BEFORE INCOME TAXES
INCOME TAX PROVISION (BENEFIT)
Net (loss) income
% of revenue0.1%-16.9%12.8%21.0%
(LOSS) EARNINGS PER ORDINARY SHARE:
(Loss) earnings per ordinary share- basic
(Loss) earnings per ordinary share - diluted
COMPREHENSIVE (LOSS) INCOME:
Net Income——
% of revenue0.1%-16.9%——